Cargando…

Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules

BACKGROUND AND OBJECTIVE: SHP465 mixed amphetamine salts extended release is a once-daily, single-entity, mixed amphetamine salts capsule product for attention-deficit/hyperactivity disorder. The objective of this study was to evaluate amphetamine pharmacokinetics following SHP465 mixed amphetamine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yi, Yu, Ming, Yan, Brian, Martin, Patrick, Robertson, Brigitte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544597/ https://www.ncbi.nlm.nih.gov/pubmed/30911906 http://dx.doi.org/10.1007/s40268-019-0267-y

Ejemplares similares

Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder
por: Adler, Lenard A., et al.
Publicado: (2020)

Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder
por: Surman, Craig B. H., et al.
Publicado: (2019)

A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder
por: Mattingly, Greg, et al.
Publicado: (2020)

SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study
por: Brams, Matthew, et al.
Publicado: (2018)

Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder
por: Ilic, Katarina, et al.
Publicado: (2021)

Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study
por: Weisler, Richard H., et al.
Publicado: (2017)

Improved Executive Function in Adults Diagnosed With Attention-Deficit/ Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment With SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Randomized, Placebo-Controlled Studies
por: Brown, Thomas E., et al.
Publicado: (2020)

Prolonged Peripheral Immunosuppressive Responses as Consequences of Random Amphetamine Treatment, Amphetamine Withdrawal and Subsequent Amphetamine Challenges in Rats
por: Glac, Wojciech, et al.
Publicado: (2021)

Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
por: Gouzoulis-Mayfrank, Euphrosyne, et al.
Publicado: (2009)

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
por: Pardo, Antonio, et al.
Publicado: (2021)

The ergogenic effect of amphetamine
por: Zaretsky, Dmitry V, et al.
Publicado: (2014)

A kinetic account for amphetamine-induced monoamine release
por: Hasenhuetl, Peter S., et al.
Publicado: (2018)

Ecstasy and amphetamines : global survey, 2003.
Publicado: (2003)

Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink
por: Ermer, James, et al.
Publicado: (2016)

Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States
por: Sembower, Mark A., et al.
Publicado: (2013)

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2018)

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study
por: Jayaram-Lindström, N, et al.
Publicado: (2017)

Delusional Parasitosis in a Female Treated with Mixed Amphetamine Salts: A Case Report and Literature Review
por: Buscarino, Martha, et al.
Publicado: (2012)

Sedation After a Trial of Mixed Amphetamine Salts in a Boy with Attention-Deficit/ Hyperactivity Disorder
por: Awami, Raed Al, et al.
Publicado: (2020)

Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine
por: Jian-min, Chen, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Does illicit amphetamine seizures quantity associated with amphetamine use disorder related admissions in Saudi Arabia?
por: Ramadan, Majed, et al.
Publicado: (2023)

Atrial flutter with aberrant conduction in a patient taking amphetamine salts and caffeine
por: Mugmon, Marc
Publicado: (2012)

Amphetamine Elicits Opposing Actions on Readily Releasable and Reserve Pools for Dopamine
por: Covey, Dan P., et al.
Publicado: (2013)

AMPHETAMINE IN CLINICAL MEDICINE: ACTIONS AND USES
Publicado: (1956)

Amphetamine recapitulates developmental programs in the zebrafish
por: Cadet, Jean Lud
Publicado: (2009)

Association of Leukocytosis with Amphetamine and Cocaine Use
por: Richards, John R., et al.
Publicado: (2014)

Orexinergic neurotransmission in temperature responses to amphetamines
por: Molkov, Yaroslav I, et al.
Publicado: (2013)

An Argument for Amphetamine-Induced Hallucinations in an Invertebrate
por: Lee, Anne H., et al.
Publicado: (2018)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Rhabdomyolysis and the Use of Low-Dose Amphetamine
por: Swisher, Austin R, et al.
Publicado: (2022)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Argon prevents the development of locomotor sensitization to amphetamine and amphetamine-induced changes in mu opioid receptor in the nucleus accumbens
por: David, Hélène N, et al.
Publicado: (2014)

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2019)

The effects of caffeine and d-amphetamine on spatial span task in healthy participants
por: Kassim, Faiz M., et al.
Publicado: (2023)

Impact of adolescent ethanol exposure and adult amphetamine self-administration on evoked striatal dopamine release in male rats
por: Granholm, L., et al.
Publicado: (2015)

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day
por: Faraone, Stephen V., et al.
Publicado: (2023)

Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers
por: Mick, Inge, et al.
Publicado: (2016)

Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls
por: Schrantee, Anouk, et al.
Publicado: (2015)

Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
por: López, Frank A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g56uu4sg2vagvjegfp9oi12ls1